Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups
and Laboratory Diagnostics
PROPOSED NEW MEDICARE RULES by the Office of the Investigator General (OIG) dealing with “discriminatory billing practices” and “usual charges” should be seen as part of a larger trend. The government doesn’t have the money to pay for Medicare and Medicaid. Thus, it is exploring indirect ways to reduce the amount of money it pays …
Chipping Away at Laboratory Reimbursement Read More »
CEO SUMMARY: Federal regulators are taking another crack at defining “usual charges.” Language in the proposed rules published last month precisely defines which payers should be included in determining “usual charges” and what charge basis to use for specific payers. Once effective, the new rules will have financial impact on many laboratories, particularly those known …
OIG Moves to Address “Usual Charge” Issue Read More »
CEO SUMMARY: As new diagnostic technologies move through the development pipeline and into widespread clinical use, the scientific knowledge and skill sets needed by laboratory staff and management will change. The emphasis in laboratory medicine will evolve to include more molecular technology, but this evolution will proceed incrementally, giving all laboratories time to adapt. RAPID …
No Disruptive Technology In Lab Industry’s Future Read More »
CEO SUMMARY: This exclusive intelligence briefing predicts how specific new technologies may drive changes in the laboratory-testing marketplace during the next five years. The key message is that change is expected to be incremental, not disruptive—given the technology known to be in development at this time. But the more provocative insight relates to how even …
Looking at Fast-Growth And Slow-Growth Areas In Diagnostic Testing Read More »
GROWTH IN SPECIMEN VOLUME and revenues is the major challenge at the nation’s two largest laboratory corporations. How Laboratory Corporation of America and Quest Diagnostics Incorporated solve this problem will affect and influence every remaining clinical laboratory and pathology group practice in the United States. That’s because the marketing and pricing strategies of the two …
Two Blood Brothers Ramp Up Marketing of New Lab Assays Read More »
Here’s a reminder that corporate fraud didn’t bypass healthcare. Last week Albert Bergonzi, former Executive Vice President of McKesson/HBOC, pled guilty to violations of securities laws. He admitted that he had “cooked the books” around the time of HBOC’s acquisition by McKesson. In a court filing, Borgzoni declared “we falsely inflated quarterly soft- ware sales …
“October 20, 2003 Intelligence: Late Breaking Lab News” Read More »
Copyright 2020 © The Dark Report. All rights reserved.
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: customerservice@darkintelligencegroup.com